Caricamento...
Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
BACKGROUND: Regadenoson is a selective A(2A) adenosine receptor agonist indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. However, the safety, tolerability, and plasma concentrations associated with repeated doses have not previously been...
Salvato in:
| Pubblicato in: | J Nucl Cardiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5250646/ https://ncbi.nlm.nih.gov/pubmed/26607361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12350-015-0327-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|